The results of sphere formation assays showed that 31.7 ± 7.6% (mean ± SD, n = 3) of glioma cells still could form >40 um spheres after TNF-α/IL-6/sIL-6R treatment (Figure 6B). This evidence concerns the gene IL6R and central nervous system cancer.